SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (819)1/11/1999 10:10:00 AM
From: jerryriti  Read Replies (1) | Respond to of 1728
 
Alliances are getting stronger and stronger......(AFFX + GLX)+ (GLGC + PG)+ (GLGC + AFFX)= strong probability of huge success



To: Richard Haugland who wrote (819)1/12/1999 1:48:00 PM
From: Steve Lokness  Respond to of 1728
 
Richard;

Do you have any feel for what this agreement between AFFX and GLGC will mean for GLGC and their bottom line? Do you expect the products based on these chips to be highly sought after by drug developers? Any idea what it might mean to AFFX?

Do you have any knowledge of Velegene developed by IDBEF?

Thanks! Your insight to these products and developments are always appreciated.

Steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News